世界のレニン阻害剤市場2020-2025:150mg /タブレット、300mg /タブレット

【英語タイトル】Global Renin-Inhibitors Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP2112)・商品コード:LPI20AP2112
・発行会社(調査会社):LP Information
・発行日:2020年3月11日
・ページ数:131
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「レニン阻害剤の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、150mg /タブレット、300mg /タブレットなど、用途別には、45歳未満、45-55歳、55-65歳、65歳以上などに区分してまとめた調査レポートです。レニン阻害剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・レニン阻害剤の世界市場概要(サマリー)
・レニン阻害剤の企業別販売量・売上
・レニン阻害剤の企業別市場シェア
・レニン阻害剤の世界市場規模 2015年-2020年:種類別(150mg /タブレット、300mg /タブレット)
・レニン阻害剤の世界市場規模 2015年-2020年:用途別(45歳未満、45-55歳、55-65歳、65歳以上)
・レニン阻害剤の米州市場規模(アメリカ、カナダ、メキシコなど)
・レニン阻害剤のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・レニン阻害剤の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・レニン阻害剤の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・レニン阻害剤市場の成長要因・課題・動向
・レニン阻害剤の世界市場予測 2021年-2025年
・レニン阻害剤の米州市場予測(アメリカ、カナダ、メキシコなど)
・レニン阻害剤のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・レニン阻害剤の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・レニン阻害剤の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・レニン阻害剤の世界市場予測:種類別(150mg /タブレット、300mg /タブレット)
・レニン阻害剤の世界市場予測:用途別(45歳未満、45-55歳、55-65歳、65歳以上)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Renin-Inhibitors market will register a 7.1% CAGR in terms of revenue, the global market size will reach $ 102.2 million by 2025, from $ 78 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Renin-Inhibitors business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Renin-Inhibitors market by type, application, key manufacturers and key regions and countries.

This study considers the Renin-Inhibitors value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
150mg/Tablet
300mg/Tablet

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Age below 45
Age 45-55
Age 55-65
Age above 65

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Noden Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Renin-Inhibitors consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Renin-Inhibitors market by identifying its various subsegments.
Focuses on the key global Renin-Inhibitors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Renin-Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Renin-Inhibitors submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Renin-Inhibitors Consumption 2015-2025
2.1.2 Renin-Inhibitors Consumption CAGR by Region
2.2 Renin-Inhibitors Segment by Type
2.2.1 150mg/Tablet
2.2.2 300mg/Tablet
2.3 Renin-Inhibitors Consumption by Type
2.3.1 Global Renin-Inhibitors Consumption Market Share by Type (2015-2020)
2.3.2 Global Renin-Inhibitors Revenue and Market Share by Type (2015-2020)
2.3.3 Global Renin-Inhibitors Sale Price by Type (2015-2020)
2.4 Renin-Inhibitors Segment by Application
2.4.1 Age below 45
2.4.2 Age 45-55
2.4.3 Age 55-65
2.4.4 Age above 65
2.5 Renin-Inhibitors Consumption by Application
2.5.1 Global Renin-Inhibitors Consumption Market Share by Type (2015-2020)
2.5.2 Global Renin-Inhibitors Value and Market Share by Type (2015-2020)
2.5.3 Global Renin-Inhibitors Sale Price by Type (2015-2020)

3 Global Renin-Inhibitors by Company
3.1 Global Renin-Inhibitors Sales Market Share by Company
3.1.1 Global Renin-Inhibitors Sales by Company (2018-2020)
3.1.2 Global Renin-Inhibitors Sales Market Share by Company (2018-2020)
3.2 Global Renin-Inhibitors Revenue Market Share by Company
3.2.1 Global Renin-Inhibitors Revenue by Company (2018-2020)
3.2.2 Global Renin-Inhibitors Revenue Market Share by Company (2018-2020)
3.3 Global Renin-Inhibitors Sale Price by Company
3.4 Global Renin-Inhibitors Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Renin-Inhibitors Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Renin-Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Renin-Inhibitors by Regions
4.1 Renin-Inhibitors by Regions
4.2 Americas Renin-Inhibitors Consumption Growth
4.3 APAC Renin-Inhibitors Consumption Growth
4.4 Europe Renin-Inhibitors Consumption Growth
4.5 Middle East & Africa Renin-Inhibitors Consumption Growth

5 Americas
5.1 Americas Renin-Inhibitors Consumption by Countries
5.1.1 Americas Renin-Inhibitors Consumption by Countries (2015-2020)
5.1.2 Americas Renin-Inhibitors Value by Countries (2015-2020)
5.2 Americas Renin-Inhibitors Consumption by Type
5.3 Americas Renin-Inhibitors Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Renin-Inhibitors Consumption by Regions
6.1.1 APAC Renin-Inhibitors Consumption by Regions (2015-2020)
6.1.2 APAC Renin-Inhibitors Value by Regions (2015-2020)
6.2 APAC Renin-Inhibitors Consumption by Type
6.3 APAC Renin-Inhibitors Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Renin-Inhibitors by Countries
7.1.1 Europe Renin-Inhibitors Consumption by Countries (2015-2020)
7.1.2 Europe Renin-Inhibitors Value by Countries (2015-2020)
7.2 Europe Renin-Inhibitors Consumption by Type
7.3 Europe Renin-Inhibitors Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Renin-Inhibitors by Countries
8.1.1 Middle East & Africa Renin-Inhibitors Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Renin-Inhibitors Value by Countries (2015-2020)
8.2 Middle East & Africa Renin-Inhibitors Consumption by Type
8.3 Middle East & Africa Renin-Inhibitors Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Renin-Inhibitors Distributors
10.3 Renin-Inhibitors Customer

11 Global Renin-Inhibitors Market Forecast
11.1 Global Renin-Inhibitors Consumption Forecast (2021-2025)
11.2 Global Renin-Inhibitors Forecast by Regions
11.2.1 Global Renin-Inhibitors Forecast by Regions (2021-2025)
11.2.2 Global Renin-Inhibitors Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Renin-Inhibitors Forecast by Type
11.8 Global Renin-Inhibitors Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Company Information
12.1.2 Renin-Inhibitors Product Offered
12.1.3 Novartis Renin-Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Noden Pharma
12.2.1 Company Information
12.2.2 Renin-Inhibitors Product Offered
12.2.3 Noden Pharma Renin-Inhibitors Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Noden Pharma Latest Developments

13 Research Findings and Conclusion



★調査レポート[世界のレニン阻害剤市場2020-2025:150mg /タブレット、300mg /タブレット] (コード:LPI20AP2112)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のレニン阻害剤市場2020-2025:150mg /タブレット、300mg /タブレット]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆